The Cigna Group — Jan 30, 2025 release

s 1,2 is projected to be at least $7.9 billion, or at least $29.50   per share   • Board of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of $6.0 billion in incremental share repurchase authorization, bringing total authorization to $10.3 billion   BLOOMFIELD, CT, January 30, 2025   – Global health company The Cigna Group (NYSE: CI) today reported 2024 results, reflecting continued strength in Evernorth Health Services, while Cigna Healthcare results were impacted by higher stop loss medical costs. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are taking corrective actions to address these near-term pressures and we are simultaneously taking steps to further advance our long-term growth strategy,” said David M. Cordani, chairman and CEO of The Cigna Group. “Through a dynamic environment, we are continuing to focus on building a sustainable model for healthcare by addressing the areas that matter most to our patients and clients, including greater transparency, support, and value.” Shareholders’ net income for fourth quarter 2024 was $1.4 billion , or $5.13 per share, compared with $1.0 billion, or $3.49 per share, for fourth quarter 2023 . The Cigna Group's adjusted income from operations 1 for fourth quarter 2024 was $1.8 billion , or $6.64 per share, c